Skip to main content
Caplight Logo









Overland ADCT BioPharma

Overland ADCT BioPharma

Private
ShanghaiHealthcare & Life Scienceshttps://overlandpharma.com

Last Round

Joint Venture

Dec 14, 2020

Company Overview

Overland ADCT BioPharma operates in Healthcare & Life Sciences and is based in Shanghai. It was founded in 2020.

Overland ADCT BioPharma is a biopharmaceutical company that develops and commercializes antibody drug conjugate (ADC) product candidates for hematologic and solid tumors in Greater China and Singapore.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Overland ADCT BioPharma Comparables

Compare Overland ADCT BioPharma with similar companies based on industry and business-model similarity.

Overland ADCT BioPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kelun-Biotech
79%
Duality Biotherapeutics Inc
77%
Lepu Biopharma
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Overland ADCT BioPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Joint VentureDec 14, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Overland ADCT BioPharma Filings

Explore SEC and related filing metadata, where available.

Overland ADCT BioPharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Overland ADCT BioPharma's valuation, stock price, and market status.

Is Overland ADCT BioPharma a public or private company?

Overland ADCT BioPharma is a private company.

What is the current stock price of Overland ADCT BioPharma?

Overland ADCT BioPharma is a private company, so its shares have no public market price. Caplight tracks Overland ADCT BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Overland ADCT BioPharma worth (valuation)?

Valuation information for Overland ADCT BioPharma is not publicly available.

Can I buy Overland ADCT BioPharma stock?

Overland ADCT BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Overland ADCT BioPharma's last funding round?

Overland ADCT BioPharma's most recent funding round was Joint Venture on December 14, 2020.

Who are the main investors in Overland ADCT BioPharma?

Investor information for Overland ADCT BioPharma is not publicly disclosed.

Will Overland ADCT BioPharma IPO soon?

No public IPO plans have been announced for Overland ADCT BioPharma.

How can I track Overland ADCT BioPharma secondary market activity?

Caplight tracks bids, offers, and trades in Overland ADCT BioPharma's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Year Founded2020
Last FundingDec 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?